LEXINGTON, Mass., Feb. 27, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 32nd Annual Cowen and Company Health Care Conference at 1:30 p.m. EST on March 5, 2012, in Boston, MA.
